Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy
Importance A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral
therapy (ART) as a prevention strategy is the absolute risk of HIV transmission through …
therapy (ART) as a prevention strategy is the absolute risk of HIV transmission through …
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
…, P Sudre, M Flepp, H Furrer, P Francioli, R Weber - The Lancet, 1999 - thelancet.com
Background The efficacy of highly active antiretroviral therapy (HAART) in suppression of
HIV-1 is well documented. We investigated virological and clinical outcomes of HAART in …
HIV-1 is well documented. We investigated virological and clinical outcomes of HAART in …
Human microsporidial infections
R Weber, RT Bryan, DA Schwartz… - Clinical microbiology …, 1994 - Am Soc Microbiol
Microsporidia are obligate intracellular spore-forming protozoal parasites belonging to the
phylum Microspora. Their host range is extensive, including most invertebrates and all …
phylum Microspora. Their host range is extensive, including most invertebrates and all …
Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study
N Friis-Møller, R Weber, P Reiss, R Thiébaut, O Kirk… - Aids, 2003 - journals.lww.com
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among
HIV-infected persons, and to investigate any association between such risk factors, stage …
HIV-infected persons, and to investigate any association between such risk factors, stage …
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration
Background With the advent of effective antiretroviral treatment, the life expectancy for
people with HIV is now approaching that seen in the general population. Consequently, the …
people with HIV is now approaching that seen in the general population. Consequently, the …
[HTML][HTML] Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy …
…, N Nwokolo, A Rieger, JM Prins, A Blaxhult, R Weber… - The Lancet, 2019 - thelancet.com
Background The level of evidence for HIV transmission risk through condomless sex in
serodifferent gay couples with the HIV-positive partner taking virally suppressive antiretroviral …
serodifferent gay couples with the HIV-positive partner taking virally suppressive antiretroviral …
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on …
SW Worm, C Sabin, R Weber, P Reiss… - The Journal of …, 2010 - academic.oup.com
Background . The risk of myocardial infarction (MI) in patients with human immunodeficiency
virus (HIV) infection has been assessed in 13 anti-HIV drugs in the Data Collection on …
virus (HIV) infection has been assessed in 13 anti-HIV drugs in the Data Collection on …
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study
Background Evidence on the effectiveness of highly active antiretroviral therapy (HAART)
for HIV-infected individuals is limited. Most clinical trials examined surrogate endpoints over …
for HIV-infected individuals is limited. Most clinical trials examined surrogate endpoints over …
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
…, B Bertisch, E Bernasconi, R Weber… - Clinical infectious …, 2011 - academic.oup.com
… designed the study; Barbara Hasse wrote the first draft; and Barbara Hasse, Bruno
Ledergerber and Rainer Weber wrote the final version of the manuscript. Bruno Ledergerber …
Ledergerber and Rainer Weber wrote the final version of the manuscript. Bruno Ledergerber …
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
…, A Manrique, M Huber, M Rehr, A Oxenius, R Weber… - Nature medicine, 2005 - nature.com
To determine the protective potential of the humoral immune response against HIV-1 in vivo
we evaluated the potency of three neutralizing antibodies (2G12, 2F5 and 4E10) in …
we evaluated the potency of three neutralizing antibodies (2G12, 2F5 and 4E10) in …